Prognostic Factors for Recurrence-Free Survival in Patients with HER2-Positive Early-Stage Breast Cancer Treated with Adjuvant Trastuzumab
2019 ◽
Vol 12
(8)
◽
pp. 815-824
◽
Keyword(s):
2020 ◽
pp. 1-10
◽
2005 ◽
Vol 23
(27)
◽
pp. 6631-6638
◽